3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
3
Lung Neoplasms
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Synovial
2
Sarcoma
2
Liposarcoma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Nodule
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Interventions
Temozolomide
12
Magnetic Resonance Spectroscopy
9
Radiotherapy
6
Surveys and Questionnaires
5
Blood Specimen Collection
4
Transurethral Resection of Bladder
3
Surgical Procedures, Operative
3
Radiation
3
Perfusion Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Lomustine
2
Immunotherapy
2
Drug Therapy
2
Chemoradiotherapy
2
Amplified Fragment Length Polymorphism Analysis
2
regorafenib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
gadodiamide
1
apatinib
1
Ultrasonography
1
Trail Making Test
1
Therapies, Investigational
1
Tablets
1
Standard of Care
1
Specimen Handling
1
Sampling Studies
1
Re-Irradiation
1
Quality of Life
1
Psychometrics
1
Proton Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Glioblastoma
×
Molecular Diagnostic Techniques
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled